PACT oxygen
based PACT compounds
PDT
PACT agents
mechanisms of PACT
hypoxic cancer models
clinical development of PACT compounds
efficacy
Hypoxic Tumour Models
photoactivated chemotherapy
cancer cells
hypoxic tumours
prodrug activation
Photoactivatable Ruthenium-based Chemotherapy
molecular oxygen
light-absorbing prodrug
anticancer prodrug
low oxygen concentrations
light irradiation
local activation
Concept project
commercial potential of ruthenium
high resistance
pre
photodynamic therapy
selection of  Ru
clinics
business analysts
patent attorney
plan
Proof
new class of phototherapy
network of collaborators
toxicity
Grant
existing therapies
collaboration
diseased tissue
treatment
consequence
principle
effects
normoxic conditions
patient